Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674995016 | Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3674997012 | Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Is a | Cyclopenthiazide and oxprenolol only product in oral dose form | true | Inferred relationship | Some | ||
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has precise active ingredient | Oxprenolol hydrochloride | true | Inferred relationship | Some | 1 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has BoSS | Oxprenolol hydrochloride | true | Inferred relationship | Some | 1 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has BoSS | Cyclopenthiazide | true | Inferred relationship | Some | 2 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has precise active ingredient | Cyclopenthiazide | true | Inferred relationship | Some | 2 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has manufactured dose form | Extended-release oral tablet | true | Inferred relationship | Some | ||
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has BoSS | Cyclopenthiazide | false | Inferred relationship | Some | 1 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has precise active ingredient | Oxprenolol hydrochloride | false | Inferred relationship | Some | 2 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has BoSS | Oxprenolol hydrochloride | false | Inferred relationship | Some | 2 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength numerator value | 250 | false | Inferred relationship | Some | 1 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has presentation strength numerator value | 160 | false | Inferred relationship | Some | 2 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Has precise active ingredient | Cyclopenthiazide | false | Inferred relationship | Some | 1 | |
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Is a | Cyclopenthiazide- and oxprenolol-containing product in oral dose form | false | Inferred relationship | Some | ||
Cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 mg prolonged-release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets